BRM/BRG1 ATP Inhibitor-1, CAS [[2270879-17-7]] Preis auf Anfrage

Produktübersicht

• Artikelname: BRM/BRG1 ATP Inhibitor-1, CAS [[2270879-17-7]] Preis auf Anfrage
• Artikelnummer: MCE-HY-119374
• Hersteller Artikelnummer: HY-119374
• Alternativnummer: MCE-HY-119374-5MG,MCE-HY-119374-100MG,MCE-HY-119374-50MG,MCE-HY-119374-10MMX1ML,MCE-HY-119374-25MG,MCE-HY-119374-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

BRM/BRG1 ATP Inhibitor-1 (compound 14) is an orally active allosteric dual brahma homolog (BRM)/SWI/SNF related matrix associated actin dependent regulator of chromatin subfamily A member 2 (SMARCA2) and brahma related gene 1 (BRG1)/SMARCA4 ATPase activity inhibitor, both IC50s are below 0.005 µM. BRM/BRG1 ATP Inhibitor-1 has anticancer activity[1].

Produkteigenschaften

• Molekulargewicht: 318.27
• Reinheit: 99.72
• CAS Nummer: [2270879-17-7]
• Formel: C11H9F3N4O2S
• Target-Kategorie: Epigenetic Reader Domain

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound